Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...

Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...

Please provide your email address to receive an email when new articles are posted on . Prophylactic inferior vena cava filter placement declined in the United States from 2005 to 2014, but rates ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

The latest study to tackle the safety and efficacy of inferior vena cava (IVC) filters—this time in trauma patients—has found no benefit of device insertion in reducing symptomatic pulmonary embolism ...

Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into pulmonary embolisms (PE), according to the findings of the ...

Inferior vena cava (IVC) filters are widely used in patients who cannot take blood thinners. The IVC is the largest vein in the body, running from the legs to the chest. IVC filters keep blood clots ...

Use of inferior vena cava (IVC) filters appears to offer no mortality benefit — and may confer a mortality risk — in older adults with pulmonary embolism (PE), a study has shown. The results of the ...

Two medical device companies that were hit last month with a $33 million verdict over their allegedly defective blood filter devices are seeking to have the award overturned. Rex Medical and Argon ...